Senuom 2 Ml 100 mg Solution for injection
PDF Leaflet Revision Date: November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Routine and immediate reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Dosage (summary)
4 mg/kg for profound blockade, 2 mg/kg for shallow blockade, 16 mg/kg for immediate reversal at 3 mins.
Onset of Action / Duration
Onset: Rapid, Duration: Varies based on dose.
Special Populations
- Renal impairment
- Elderly patients
- Obese patients
- Hepatic impairment
- Pediatric patients (under 7 years)
Pregnancy & Breastfeeding
Safety not established in pregnancy; excretion in breast milk not studied.
Key Drug Interactions
- Toremifene
- Fusidic acid
- Hormonal contraceptives
Contraindications
- Hypersensitivity to sugammadex or excipients
- Severe renal impairment
Common side effects
- Cough
- Dysgeusia
- Prolonged neuromuscular blockade
Counselling Points
- Monitor for recurrence of neuromuscular blockade.
- Use caution in patients with renal or hepatic impairment.
- Inform about potential hypersensitivity reactions.
Serious warnings
- Marked bradycardia
- Hypersensitivity reactions including anaphylaxis
- Not for reversal of depolarizing neuromuscular blockers
Important Disclaimer
The Senuom 2 Ml 100 mg Solution for injection professional information leaflet below is the property of Cipla Medpro (Pty)Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
